Ultimi Movimenti
Bio Protocol (bio) è attualmente quotato a 0,02 USD con un volume di scambio nelle 24 ore di 12,2 Mln USD. Nelle ultime 24 ore, Bio Protocol ha subito una diminuzione del -2,2%. La capitalizzazione di mercato di Bio Protocol è pari a 50,78 Mln USD, con 2,15 Mld bio in circolazione. Per chi desidera acquistare o scambiare Bio Protocol, OKX offre modi sicuri ed efficienti per farlo
- Capitalizzazione di mercato
- 50,78 Mln USD
- volume delle ultime 24 ore
- 12,2 Mln USD
- Offerta circolante
- 2,15 Mld bio
Domande Frequenti sul Prestito di Bio Protocol (bio)
- What are the borrowing and lending eligibility requirements for Bio Protocol (BIO) on this platform, including geographic restrictions, minimum deposits, KYC levels, and any BIO-specific constraints?
- Eligibility for lending BIO on this platform combines geographic coverage, minimum deposit sizes, and KYC tier distinctions. BIO lends are generally available to restricted geographies with compliant accounts, but some regions may face complete or partial restrictions due to regulatory constraints. The minimum BIO deposit to participate in lending tends to be around a small but non-zero threshold (for example, a typical minimum of 0.5 BIO) to access lending pools, with higher tiers providing increased borrowing power or favorable rates. KYC requirements vary by tier: basic verification may be enough for deposit-and-withdraw access, while higher tiers can unlock larger lending limits and the ability to participate in private collateralized pools or premium rate programs. Platform-specific rules include occasional eligibility constraints tied to regulatory regimes, such as limits on lending to non-residents or restrictions on institutional accounts. In practice, Bio Protocol users should complete at least the platform’s ID verification and address verification to access standard lending pools, and monitor any country-specific policy notices published by the platform. Always check the latest regional notices and KYC tier mappings in the BIO lending dashboard, since eligibility can shift with regulatory changes and product updates.
